ASYMCHEM LAB.(TIAN.)H YC1 Market Cap ($377.48 Million)
Market Cap & Net Worth: ASYMCHEM LAB.(TIAN.)H YC1 (7K90)
ASYMCHEM LAB.(TIAN.)H YC1 market cap. ASYMCHEM LAB.(TIAN.)H YC1 (F:7K90) has a market capitalization of $377.48 Million (€322.88 Million) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #13374 globally and #1403 in its home market, demonstrating a -14.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ASYMCHEM LAB.(TIAN.)H YC1's stock price €11.60 by its total outstanding shares 27834510 (27.83 Million). Also see ASYMCHEM LAB.(TIAN.)H YC1 cash conversion from operations for how efficiently the company converts equity into cash flow.
ASYMCHEM LAB.(TIAN.)H YC1 Market Cap History (2022–2026)
ASYMCHEM LAB.(TIAN.)H YC1 market cap history from 2022 to 2026. Data shows change from $243.91 Million to $377.48 Million (-1.67% CAGR). Check today's stock price for ASYMCHEM LAB.(TIAN.)H YC1 for real-time trading data and today's change.
ASYMCHEM LAB.(TIAN.)H YC1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ASYMCHEM LAB.(TIAN.)H YC1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ASYMCHEM LAB.(TIAN.)H YC1 (7K90) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.04x
ASYMCHEM LAB.(TIAN.)H YC1's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.22x
ASYMCHEM LAB.(TIAN.)H YC1's market cap is 0.22 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $243.91 Million | $10.26 Billion | $3.30 Billion | 0.02x | 0.07x |
| 2023 | $228.60 Million | $7.83 Billion | $2.27 Billion | 0.03x | 0.10x |
| 2024 | $208.27 Million | $5.80 Billion | $948.95 Million | 0.04x | 0.22x |
| 2025 | $247.32 Million | $6.67 Billion | $1.13 Billion | 0.04x | 0.22x |
Competitor Companies of 7K90 by Market Capitalization
Companies near ASYMCHEM LAB.(TIAN.)H YC1 in the global market cap rankings as of November 1, 2026. Also see ASYMCHEM LAB.(TIAN.)H YC1 total assets for a full breakdown of the balance sheet.
Key companies related to ASYMCHEM LAB.(TIAN.)H YC1 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of ASYMCHEM LAB.(TIAN.)H YC1 (2022–2026)
Market capitalization of ASYMCHEM LAB.(TIAN.)H YC1 from 2022 to today. Between 2022 and today, ASYMCHEM LAB.(TIAN.)H YC1's market cap moved from $243.91 Million to $ 377.48 Million, with a yearly change of -1.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €377.48 Million | +52.63% |
| 2025 | €247.32 Million | +18.75% |
| 2024 | €208.27 Million | -8.89% |
| 2023 | €228.60 Million | -6.28% |
| 2022 | €243.91 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of ASYMCHEM LAB.(TIAN.)H YC1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $377.48 Million USD |
| MoneyControl | $377.48 Million USD |
| MarketWatch | $377.48 Million USD |
| marketcap.company | $377.48 Million USD |
| Reuters | $377.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ASYMCHEM LAB.(TIAN.)H YC1
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, incl… Read more